AGP Executive Report
Last update: an hour agoMedical Evidence Push: A new trial reports “significant improvements” in pain and quality of life for fibromyalgia, rheumatoid arthritis, and osteoarthritis patients using CBD/THC and other cannabinoid mixes, with sleep and mental health among the biggest wins. Regulatory Pressure on Hemp: A top marijuana reform group warns Congress won’t stop a federal crackdown that could effectively ban many hemp THC products by counting multiple THC forms toward the 0.3% limit. Industry & Capital: FundCanna secured up to $60M in credit to finance cannabis businesses as rescheduling talk heats up, while MedX Holdings flagged strong Q1 growth and expansion. Legal Backlash: A new Illinois/Connecticut class action alleges cannabis companies oversold medical benefits and downplayed risks. On-the-ground Enforcement: Durban authorities arrested 23 undocumented people and shut five non-compliant shops in a CBD crackdown. Access & Advocacy: Kenya-linked pharmacist-researcher Dr Phyllis Kimani is urging epilepsy to be treated as a public health priority.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
